Cargando…

Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region

BACKGROUND: According to the latest guidelines, in patients with high-risk nodules with indeterminate cytology, diagnostic lobectomy should be the preferable surgical approach in the absence of factors that suggest a total thyroidectomy. METHODS: This retrospective observational study has as its mai...

Descripción completa

Detalles Bibliográficos
Autores principales: Loderer, Tommaso, Bonati, Elena, Donato, Valentina, Viani, Lorenzo, Cozzani, Federico, Del Rio, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506119/
https://www.ncbi.nlm.nih.gov/pubmed/37727346
http://dx.doi.org/10.21037/gs-22-491
_version_ 1785107054838415360
author Loderer, Tommaso
Bonati, Elena
Donato, Valentina
Viani, Lorenzo
Cozzani, Federico
Del Rio, Paolo
author_facet Loderer, Tommaso
Bonati, Elena
Donato, Valentina
Viani, Lorenzo
Cozzani, Federico
Del Rio, Paolo
author_sort Loderer, Tommaso
collection PubMed
description BACKGROUND: According to the latest guidelines, in patients with high-risk nodules with indeterminate cytology, diagnostic lobectomy should be the preferable surgical approach in the absence of factors that suggest a total thyroidectomy. METHODS: This retrospective observational study has as its main aim the evaluation of the cases that underwent surgery, for Bethesda class IV nodules in our iodocarent geographical area. Particular attention was paid to carcinoma incidence, preoperative nodule size, histological characteristics of the neoplasm, surgical approach and eventual need of radiometabolic treatment. A total of 320 patients were included that underwent surgery for Bethesda IV nodules, between January 2010 and December 2020, at the General Surgical Clinic of the University Hospital of Parma, Italy. RESULTS: A total of 230 total thyroidectomies (71.9%) and 90 lobectomies (28.1%) were performed. Our data showed a strong impact of the 2015 ATA Guidelines on the surgical approach choice, with a progressive propensity towards a conservative approach and an increase of lobectomies from 7.2% to 41.5% after the new guidelines introduction. However, in our sample the percentage of lobectomies remains below 50%; this data is certainly influenced by the number of cases of multinodular pathology, often bilateral, in our geographical area. The nodules malignancy rate resulted 28.8%. Our data showed that increasing size correlated with an increasing malignancy rate (P<0.01), and follicular carcinomas were found to be larger than papillary carcinomas (P<0.001). A statistically significant correlation also emerged between nodule size increase and local/lymphovascular invasion (P<0.05). On the other hand, there was no statistically significant correlation between nodule size and multifocality, and between nodule size and presence of lymph node metastases. Out of the patients where it was possible to find this data, 66% underwent radioiodiometabolic treatment: 59% with papillary carcinoma, and 85% with follicular carcinoma. CONCLUSIONS: In patients with Bethesda IV thyroid nodules, diagnostic lobectomy should be the preferable surgical approach in absence of factors that suggest total thyroidectomy. In our opinion, total thyroidectomy remains the first choice in large nodules (≥4 cm) as these nodules have a high malignancy rate, greater local/lymphovascular invasion and a consequent frequent indication for post-operative radiometabolic treatment.
format Online
Article
Text
id pubmed-10506119
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-105061192023-09-19 Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region Loderer, Tommaso Bonati, Elena Donato, Valentina Viani, Lorenzo Cozzani, Federico Del Rio, Paolo Gland Surg Original Article BACKGROUND: According to the latest guidelines, in patients with high-risk nodules with indeterminate cytology, diagnostic lobectomy should be the preferable surgical approach in the absence of factors that suggest a total thyroidectomy. METHODS: This retrospective observational study has as its main aim the evaluation of the cases that underwent surgery, for Bethesda class IV nodules in our iodocarent geographical area. Particular attention was paid to carcinoma incidence, preoperative nodule size, histological characteristics of the neoplasm, surgical approach and eventual need of radiometabolic treatment. A total of 320 patients were included that underwent surgery for Bethesda IV nodules, between January 2010 and December 2020, at the General Surgical Clinic of the University Hospital of Parma, Italy. RESULTS: A total of 230 total thyroidectomies (71.9%) and 90 lobectomies (28.1%) were performed. Our data showed a strong impact of the 2015 ATA Guidelines on the surgical approach choice, with a progressive propensity towards a conservative approach and an increase of lobectomies from 7.2% to 41.5% after the new guidelines introduction. However, in our sample the percentage of lobectomies remains below 50%; this data is certainly influenced by the number of cases of multinodular pathology, often bilateral, in our geographical area. The nodules malignancy rate resulted 28.8%. Our data showed that increasing size correlated with an increasing malignancy rate (P<0.01), and follicular carcinomas were found to be larger than papillary carcinomas (P<0.001). A statistically significant correlation also emerged between nodule size increase and local/lymphovascular invasion (P<0.05). On the other hand, there was no statistically significant correlation between nodule size and multifocality, and between nodule size and presence of lymph node metastases. Out of the patients where it was possible to find this data, 66% underwent radioiodiometabolic treatment: 59% with papillary carcinoma, and 85% with follicular carcinoma. CONCLUSIONS: In patients with Bethesda IV thyroid nodules, diagnostic lobectomy should be the preferable surgical approach in absence of factors that suggest total thyroidectomy. In our opinion, total thyroidectomy remains the first choice in large nodules (≥4 cm) as these nodules have a high malignancy rate, greater local/lymphovascular invasion and a consequent frequent indication for post-operative radiometabolic treatment. AME Publishing Company 2023-07-04 2023-07-31 /pmc/articles/PMC10506119/ /pubmed/37727346 http://dx.doi.org/10.21037/gs-22-491 Text en 2023 Gland Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Loderer, Tommaso
Bonati, Elena
Donato, Valentina
Viani, Lorenzo
Cozzani, Federico
Del Rio, Paolo
Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region
title Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region
title_full Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region
title_fullStr Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region
title_full_unstemmed Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region
title_short Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region
title_sort malignancy risk in bethesda class iv thyroid nodules in an iodine deficient region
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506119/
https://www.ncbi.nlm.nih.gov/pubmed/37727346
http://dx.doi.org/10.21037/gs-22-491
work_keys_str_mv AT loderertommaso malignancyriskinbethesdaclassivthyroidnodulesinaniodinedeficientregion
AT bonatielena malignancyriskinbethesdaclassivthyroidnodulesinaniodinedeficientregion
AT donatovalentina malignancyriskinbethesdaclassivthyroidnodulesinaniodinedeficientregion
AT vianilorenzo malignancyriskinbethesdaclassivthyroidnodulesinaniodinedeficientregion
AT cozzanifederico malignancyriskinbethesdaclassivthyroidnodulesinaniodinedeficientregion
AT delriopaolo malignancyriskinbethesdaclassivthyroidnodulesinaniodinedeficientregion